Valery Walker

1.4k total citations
40 papers, 1.1k citations indexed

About

Valery Walker is a scholar working on Rheumatology, Pharmacology and Epidemiology. According to data from OpenAlex, Valery Walker has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 8 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Valery Walker's work include Osteoarthritis Treatment and Mechanisms (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Respiratory Support and Mechanisms (4 papers). Valery Walker is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Respiratory Support and Mechanisms (4 papers). Valery Walker collaborates with scholars based in United States, Canada and Australia. Valery Walker's co-authors include George W. Torrance, Charlie H. Goldsmith, Peter Tugwell, Nicholas Bellamy, J.-P. Raynauld, Philip A. Band, M. Schultz, Karen Cauch‐Dudek, Urs P. Steinbrecher and Robert J. Bailey and has published in prestigious journals such as Hepatology, American Journal of Epidemiology and European Heart Journal.

In The Last Decade

Valery Walker

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valery Walker United States	16	374	350	346	323	160	40	1.1k
Katinka Albrecht Germany	24	1.3k 3.5×	214 0.6×	153 0.4×	68 0.2×	76 0.5×	105	1.8k
Ihsane Hmamouchi Morocco	20	503 1.3×	119 0.3×	144 0.4×	52 0.2×	86 0.5×	84	1.1k
Ming‐Shyan Lin Taiwan	19	137 0.4×	216 0.6×	292 0.8×	133 0.4×	28 0.2×	93	1.2k
Carlos Sánchez‐Piedra Spain	20	449 1.2×	97 0.3×	109 0.3×	90 0.3×	61 0.4×	75	918
Matthew H. Liang United States	15	498 1.3×	612 1.7×	119 0.3×	39 0.1×	136 0.8×	18	1.4k
Carrie R. Wong United States	16	49 0.1×	517 1.5×	367 1.1×	272 0.8×	24 0.1×	30	1.3k
José Álvarez-Nemegyei Mexico	19	535 1.4×	238 0.7×	169 0.5×	28 0.1×	109 0.7×	74	1.2k
Renaud Felten France	19	588 1.6×	155 0.4×	76 0.2×	31 0.1×	95 0.6×	70	1.3k
Eric D. Newman United States	16	268 0.7×	250 0.7×	219 0.6×	31 0.1×	26 0.2×	28	962
Colin O’Rourke United States	25	30 0.1×	1.0k 2.9×	106 0.3×	174 0.5×	122 0.8×	77	1.7k

Countries citing papers authored by Valery Walker

Since Specialization

Citations

This map shows the geographic impact of Valery Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valery Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valery Walker more than expected).

Fields of papers citing papers by Valery Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valery Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valery Walker. The network helps show where Valery Walker may publish in the future.

Co-authorship network of co-authors of Valery Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Valery Walker. A scholar is included among the top collaborators of Valery Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valery Walker. Valery Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levy, Carol J., et al.. (2025). Real-World HbA1c Following Initiation of the Omnipod 5 Automated Insulin Delivery System. Diabetes Technology & Therapeutics.

White, John, et al.. (2025). Validation of an Administrative Claims-based Line of Therapy Algorithm for Women with Ovarian Cancer Using Medical Chart Review. Advances in Therapy. 42(6). 2754–2766. 1 indexed citations

White, John, et al.. (2024). Reasons for switching oral antipsychotic medications and related patterns of care and costs in patients with schizophrenia initiating monotherapy treatment: Claims-linked chart study. Journal of Managed Care & Specialty Pharmacy. 30(7). 698–709. 1 indexed citations

Gould, L. Hannah, John White, Valery Walker, et al.. (2024). Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: a case-control study. American Journal of Epidemiology. 194(8). 2287–2294. 3 indexed citations

Harris, Stewart B., Kamel Mohammedi, Maureen Carlyle, et al.. (2023). Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys. Diabetes Obesity and Metabolism. 25(12). 3478–3489. 2 indexed citations

Brakenridge, Scott C., David Wilfret, Greg Maislin, et al.. (2021). Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study. The Journal of Trauma: Injury, Infection, and Critical Care. 91(2). 384–392. 4 indexed citations

Strange, Charlie, et al.. (2019). <p>Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD</p>. International Journal of COPD. Volume 14. 1377–1388. 5 indexed citations

Wei, Wenhui, Michael Andria, Valery Walker, et al.. (2019). A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD). Annals of Allergy Asthma & Immunology. 123(4). 381–388.e2. 34 indexed citations

Wei, Wenhui, Michael Andria, Valery Walker, et al.. (2017). 204 A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (AD-QUEST): Baseline treatment patterns and unmet needs assessment. Journal of Investigative Dermatology. 137(5). S35–S35. 1 indexed citations

10.

Thorne, Carter, Gilles Boire, Andrew Chow, et al.. (2017). Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study. The Open Rheumatology Journal. 11(1). 123–135. 4 indexed citations

11.

Shiozawa, Aki, Puja Khanna, Valery Walker, et al.. (2015). Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient Preference and Adherence. 9. 971–971. 25 indexed citations

12.

Caraway, David, et al.. (2015). Successful Discontinuation of Systemic Opioids After Implantation of an Intrathecal Drug Delivery System. Neuromodulation Technology at the Neural Interface. 18(6). 508–516. 22 indexed citations

13.

Bombardier, Claire, Marco Barbieri, Anju Parthan, et al.. (2011). The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Annals of the Rheumatic Diseases. 71(6). 836–844. 79 indexed citations

14.

Bellamy, Nicholas, Mary Bell, Dan Pericak, et al.. (2006). BLISS index for analyzing knee osteoarthritis trials data. Journal of Clinical Epidemiology. 60(2). 124–132. 20 indexed citations

15.

Bellamy, Nicholas, Mary Bell, Charlie H. Goldsmith, et al.. (2004). Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Annals of the Rheumatic Diseases. 64(6). 881–885. 50 indexed citations

16.

Torrance, G. W., Philip A. Band, J.-P. Raynauld, et al.. (2003). Response to Dr C. Daniel Mullins’ letter [re: Osteoarthritis and Cartilage, 2002; 10:518–27]. Osteoarthritis and Cartilage. 11(5). 379–381. 1 indexed citations

17.

Raynauld, J.-P., George W. Torrance, Philip A. Band, et al.. (2002). A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis and Cartilage. 10(7). 506–517. 193 indexed citations

18.

Torrance, George W., Valery Walker, Ronald F. Grossman, et al.. (1999). Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year. PharmacoEconomics. 16(5). 499–520. 36 indexed citations

19.

Rachlis, Anita, et al.. (1999). Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS. PharmacoEconomics. 16(1). 71–84. 6 indexed citations

20.

Walker, Valery, et al.. (1995). Health-Related Quality of Life in Patients With Major Depression Who Are Treated With Moclobemide. Journal of Clinical Psychopharmacology. 15(4 Suppl 2). 60S–67S. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact